|
Real-time
Euronext Paris
21:57:51 27/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.4490 EUR | -4.47% |
|
-19.82% | -61.88% |
| 10-23 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-22 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALNFL | Real-time | |
Deutsche Boerse AG
| 82F | Delayed | |
|
Börse Stuttgart
| 82F | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.579 | 0.731 | 0.916 |
| Spread/Res. | -22.45% | -38.58% | -50.98% |
| Spread/Supp. | +6.40% | +6.40% | +33.63% |
| Support | 0.422 | 0.422 | 0.336 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
Select your edition
All financial news and data tailored to specific country editions
